Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX8QMR
|
||||
Drug Name |
(S)-4-((5-((4-(3-chlorophenyl)-2-(2-(methylsulfonyl)ethyl)-5-oxopiperazin-1-yl)methyl)-4-methyl-1H-imidazol-1-yl)methyl)benzonitrile
|
||||
Synonyms |
CHEMBL2203624
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H28ClN5O3S
|
||||
Canonical SMILES |
Cc1ncn(Cc2ccc(cc2)C#N)c1CN3CC(=O)N(C[C@@H]3CCS(=O)(=O)C)c4cccc(Cl)c4
|
||||
InChI |
InChI=1S/C26H28ClN5O3S/c1-19-25(31(18-29-19)14-21-8-6-20(13-28)7-9-21)16-30-17-26(33)32(23-5-3-4-22(27)12-23)15-24(30)10-11-36(2,34)35/h3-9,12,18,24H,10-11,14-17H2,1-2H3/t24-/m0/s1
|
||||
InChIKey |
QUJNUEZQIXVXCJ-DEOSSOPVSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.